AXIM Biotechnologies, Inc. announced that it has appointed Michael E. Stern, MS, Ph.D., to its Medical Advisory Board. He joins the company?s four other Advisory Board members including Drs. Kelly K. Nichols, Henry D. Perry, Laura Periman, and its Chairman Joseph Tauber. Dr. Stern brings over 30 years of senior scientific, research, academic and executive level expertise with Dry Eye Disease and Ocular Surface Disease (OSD). Currently, he is a Principal and Chief Science Officer for immunEyze. Previously, he served for 26 years with Allergan where he rose to Principal Scientist and Vice-President Inflammation Research whose work included elucidating the pathophysiology of DED. Dr. Stern is currently Co-Director of Ocular Immunology at IOBA (University of Valladolid, Valladolid, Spain).